Patent 7335468 was granted and assigned to Myriad Genetics on February, 2008 by the United States Patent and Trademark Office.
Isolated protein complexes are provided comprising Tsg101 and HIV GAG or GAGp6. The protein complexes are useful in screening assays for selecting compounds effective in modulating the Tsg101-HIV GAG or GAGp6 interaction within the protein complexes.